Press Release January 07, 2021

PCI Pharma Services Majority Stake Sold to Kohlberg and Mubadala

The Private Equity team advised PCI Pharma Services, a portfolio company of Partners Group, on the sale of a majority stake in PCI to Kohlberg and Mubadala.

PCI is a recognized industry leader and trusted partner providing a broad range of integrated pharmaceutical supply chain solutions from the earliest stages of drug development through to commercial launch, and delivering ongoing supply with global capabilities for drug development and manufacturing, clinical trials services and commercial packaging services. Partners Group is a leading global private markets investment manager.

Kohlberg is a private equity firm headquartered in Mount Kisco, New York, with over 30 years of successful experience partnering with management and companies like PCI Pharma Services. Mubadala Investment Company is an Abu Dhabi-based sovereign investor.

Following the sale to private equity firm Kohlberg and Mubadala, Partners Group will retain a meaningful minority equity stake in PCI.

The Goodwin team was led by Chris Nugent, Liam Timoney, Jessica Jacobs, Lindsay Reed, Carolina Guerrero, Kaitlin Carragher, and Wenlan Geng, with invaluable assistance from Joshua Soszynski and Michael Miller, and included Janet Andolina, Alexander Plaum, Katie Leah, Jennifer Bralower, John Ilardo, Elizabeth Jordan, Sandra Lucero, James Mattus, Brittany McCants, Jeremy Slotnick, Sarah Tauman, Steve Argentieri, Jackie Klosek, Roger Cohen, Julie Tibbets, Alexander Varond, Jacob Osborn, Nathan Brodeur, Carl Bradshaw, Stan Shishkin, Rosie Maguire, Simon Fulbrook, Richard Hughes and Joana Pamukova, with invaluable assistance from Troy Root.

For more details, read the press release.